The relative risk of immune checkpoint inhibitor pneumonitis in advanced non-small- cell lung cancer: Meta-analyses of controlled clinical trials
PLoS Medicine,
by Ying Kong, Liang Hong, Xiao-cheng Xu, Yun-feng Chen, Jia Xu Objective Immune checkpoint inhibitor pneumonitis (CIP) is a…